CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 22 No. 10
INTEGRATIVE ONCOLOGY 

Graviola (Annona muricata)

Complementary Therapies, Herbs, and Other OTC Agents

By Guest Editor Barrie Cassileth, PhD1 | September 1, 2008
1 Laurance S. Rockefeller Chair and Chief, Integrative Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York

Integrative Oncology is the synthesis of mainstream care and nonpharmacologic, evidence-based complementary therapies for the control of cancer-related physical and emotional symptoms. Herb-drug interactions and other cautions are also encompassed. In this first installment of ONCOLOGY’s new department, we review “graviola.” Graviola was chosen for review because it is one of the most commonly searched terms sought by visitors to MSKCC’s “About Herbs” website. Because graviola is commonly promoted as a cancer treatment, your patients may be inclined to take it.

Herbal supplements are commonly used by cancer patients for symptom relief and also in efforts to treat the disease itself. Patients should understand that herbal supplements are not viable substitutes for mainstream cancer care. Moreover, there is substantial potential for herb-drug interactions that may reduce the efficacy of chemotherapeutic agents.

Despite the absence of supportive data, graviola, like many herbal products, is heavily promoted to cancer patients on the Internet, often with false claims of cure. Patients should be cautioned against herbal supplement use when on treatment.

Because reliable information about herbs and other dietary supplements was not readily available to oncologists who need it to counsel their patients, the MSKCC Integrative Medicine Service developed and maintains a free website. The “AboutHerbs” website (http://www.mskcc.org/AboutHerbs) now has two portals, one for oncology professionals and another for the public. Anyone may enter either portal at no cost. This site is updated continually and provides objective information on herbs and other botanicals as well as vitamins, other dietary supplements, and unproved cancer therapies. Visit the MSKCC website and watch for coverage of other common herbal products and complementary therapies in future issues of ONCOLOGY.

—Barrie Cassileth, PhD

SCIENTIFIC NAME: Annona muricata

ALSO KNOWN AS: Cherimoya, guanabana, corossol, soursop, custard apple, brazilian paw paw

USES: Graviola is used as a sedative and to treat infections, herpes, and cancer.

BACKGROUND: Graviola is an evergreen tree native to Mexico, the Carribean, and Central and South America. It is also grown in parts of Southeast Asia. The fruits, seeds, and leaves are used to treat stomach ailments, fever, parasitic infections, hypertension, and rheumatism. It is sold as capsules, tablets, powder for infusions (very dense teas), and tinctures.

RESEARCH: Acetogenins, phytochemicals isolated from the leaves, bark, and twigs of graviola, are thought to be the active ingredients. Ethanolic extracts of graviola were effective against Herpes simplex virus,[1] leishmania, a protozoan that causes leishmaniasis,[2] and the freshwater mollusk Biomphalaria glabrata, which acts as a host for the parasitic worm Schistosoma mansoni.[3]

Alkaloids extracted from graviola were found detrimental to the survival of dopaminergic nerve cells in vitro[4] and can cause neuronal dysfunction and degeneration. Graviola may also have antidepressive activity due to its ability to stimulate serotonin receptors.[5]

Extracts of graviola demonstrated cytotoxic effects against hepatoma cells[6] and doxorubicin(Drug information on doxorubicin)-resistant human mammary adenocarcinoma cells[7] by blocking ATP utilization and by inhibiting activity of plasma membrane glycoprotein. But human studies are lacking.

ADVERSE EFFECTS: Graviola may cause movement disorders and myeloneuropathy with symptoms similar to Parkinson’s disease.[5]

SUMMARY: Graviola demonstrated anticancer effects in vitro, but has not been studied in humans. Despite the lack of human data, many websites promote graviola to cancer patients based on traditional use and on the in vitro studies. Caution is required as there is no evidence of safety or efficacy.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





REFERENCES
1. Padma P et al: J Ethnopharmacol 61:81-83, 1998.
2. Jaramillo MC et al: Fitoterapia 71:183-186, 2000.
3. dos Santos AF, Sant’Ana AE: Phytomedicine 8:115-120, 2001.
4. Lannuzel A et al: Mov Disord 17:84-90, 2002.
5. Roman G: Curr Opin Neurol 11:539-544, 1998.
6. Chen JC et al: Am J Chin Med 28:175, 2000.
7. Oberlies NH, Chang CJ: J Med Chem 40:2102-2106, 1997.
For additional information, visit www.mskcc.org/AboutHerbs.


 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy